The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLLIan W. Flinn, Stephan Stilgenbauer, Peter Hillmen et al.|Blood|2018Cited by 341
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension StudyMatthew S. Davids, Ulrich Jäger, Bryone J. Kuss et al.|Clinical Cancer Research|2020Cited by 43
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Austin Kulasekararaj, Cristina Barrenetxea Lekue et al.|American Journal of Hematology|2024Cited by 42
Topography of Movement-Related Delta and Theta Brain OscillationsJános Körmendi, Zsolt Nagy|Brain Topography|2021Cited by 29
The Hungarian population-based prevalence and incidence study of neuromyelitis optica spectrum disorder.Viktoria Papp, Zsolt Illés, Anna Iljicsov et al.|University of Southern Denmark Research Portal (University of Southern Denmark)|2018Cited by 16